High-dose chemotherapy regimens for solid tumors
- 31 March 1995
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 21 (2) , 105-132
- https://doi.org/10.1016/0305-7372(95)90023-3
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.Journal of Clinical Oncology, 1993
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 1991
- A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patientsCancer Chemotherapy and Pharmacology, 1991
- Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.Journal of Clinical Oncology, 1989
- Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factorBlood, 1986
- Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised studyBritish Journal of Cancer, 1984
- IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapyBlood, 1982
- Studies on the antidiuretic effect of cyclophosphamide: Vasopressin release and sodium excretionMedical and Pediatric Oncology, 1980
- Cyclophosphamide cystitis—Identification of acrolein as the causative agentBiochemical Pharmacology, 1979
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 1979